Abstract
Objective: To investigate the RNA profile of synovial fluid (SF) from osteoarthritis (OA) patients and carry out cluster analysis of OA-related genes. Methods: RNA of SF from OA patients was isolated using RNA-specific Trizol. A cDNA library was built and subjected to the second-generation sequencing using HisSeq4000 with a data size of 8G. The sequencing reads were aligned to the UCSC human reference genome (hg38) using Tophat with default parameters. Gene function enrichment was generated using DAVID. Results: The minimum weight 0.096 µg RNA of SF sample was used for sequencing analysis, which produced 66,154,562 clean reads, 91.28% of which were matched to the reference with 2,682 genes identified. Some of the unmatchable reads matched RNAs of bacteria, mainly Pseudomonas. The detected human RNAs in samples fell into different categories of genes, including protein-coding ones, processed and unprocessed pseudogenes, and long noncoding, antisense and miscellaneous RNAs that mediate various biological functions. Interestingly, 80% of the expressed genes belonged to the mitochondrial genome. Conclusion: These results suggest that less than 0.1 µg RNA is sufficient for establishing a cDNA library and deep sequencing, and that the liquid fraction of SF contains a whole RNA repertoire that may reflect a history of previous microorganism infections.
Keywords: Osteoarthritis, knee joint, synovial fluid, transcriptome, second-generation sequencing
Introduction
Osteoarthritis (OA) is the most common arthritis and the leading cause of disability in adults. In worldwide, about 250 million people are affected, which causes a relatively large social and economic burden [1]. Partly due to increased aging and obese populations, the incidence of OA is increasing worldwide, with 83% occurring in the knee joints (KOA) [2]. The incidences of KOA and associated disability are probably higher in China than those of many developed countries, because China has its largest population in rural areas where heavy carrying is a routine part of their labor.
While OA is quite common, its definition is actually not strict but, instead, utilizes a combination of symptoms and radiographic criteria [3]. That often makes it difficult to differentiate OA from other joint diseases such as rheumatoid arthritis and undifferentiated arthritis [4]. The definition of OA is opaque in part because the etiology of OA is still impenetrable. Germane to the lack of lucid criteria for diagnosis of the different types of arthritis, the treatment and management of these diseases sometimes also becomes unspecific and ineffective, making it difficult to evaluate the treatment outcome.
There have been many different attempts to delve into the etiology and mechanisms of different joint diseases in order to differentiate one joint disease from another and to improve the diagnosis and treatment, with synovial fluid (SF) as the main sample source [5]. Actually, SF is also commonly used in evaluation of efficacy or prognosis of various treatments or management of joint diseases [6]. For example, genetic influences in various types of arthritis have been explored, and some genetic backgrounds have been found to predispose certain individuals to OA or rheumatoid arthritis [7]. There are also some studies on metabolic profile and gene expression profile of different types of arthritis [8,9], including mRNA profile, microRNA profile, matrix metalloproteinase profile, proteomic profile, and cytokine profile. Some of these studies involve a huge number of protein-specific primary antibodies. There are also some bioinformatic analyses with various databases or published data as the information sources [10]. As expected, these studies resulted in very heterogeneous data and conclusions.
Most of the above-mentioned profiling studies utilized joint tissues or synovial tissues or utilized a specific cell type of synovial tissues, such as chondrocytes, or of a SF, such as fibroblasts, whereas few studies utilized the liquid component of SF [11]. For example, few, if any, studies investigated the transcriptome of the liquid component of SF. While these published studies provide valuable information on gene expression profiles of certain synovial cell types or tissues, they do not supply an overall picture of the SF with regard of its RNA repertoire. Having a global picture of RNA in cell-free SF has its unique merits, including the possibility of a better diagnosis of joint diseases, since it is a trend in today’s medical research to use the transcriptome in diagnosis of different highly heterogeneous diseases. The liquid fraction of SF is more comparable between one situation and another, as it rules out the differences in cell type. For instance, when contrasting a healthy status to an infectious one, the SF from the patient with infection may be rife with bacteria and inflammatory cells, making the comparison reflect mainly a difference in cell types.
Since there are various types of RNAs in cell-free serum or plasma of blood samples from humans and animals, it needs to be determined whether there are some types of RNA in the liquid component of SF and whether they are at a sufficient quantity for the establishment of a cDNA library and the ensuing deep RNA sequencing to profile the RNAs.
Materials and methods
Collection, cell removal, and storage of synovial fluid
Synovial fluid (SF) was aspirated using a syringe, from the cavity of the affected knee joints of OA patients for diagnostic purposes. The procedure is a routine clinical practice and was approved by the institutional ethical committee (Approval No. 2022-028). The patients signed informed consent forms. After sending a portion of the SF sample to the hospital’s clinical laboratory for various examinations, an aliquot of the sample was transferred into a 15-mL Falcon tube (Becton, Dickinson and Company, USA) and centrifuged at 4,000 rpm for 5 min to spin down the cells. Some of cell-free portion at the top was aspirated, transferred into a new tube, and stored at -20°C for RNA extraction later.
Isolation of RNA from the liquid fraction of SF
4 mL of the cell-free SF was added to 4 mL of RNA-specific Trizol (pH 4.8) (Invitrogen, USA) until they were mixed well. After storage at room temperature for 10 min, 1 mL of the mixture was transferred to a 1.5-mL Eppendorf tube (Eppendorf AG, Germany) and 200 µL of chloroform (Sigma-aldrich Company, USA) was added, followed by mixing and storage at room temperature for 15 min. After centrifugation at 12,000 rpm for 15 min at 4°C, the aqueous fraction was collected and the protein extraction with chloroform was repeated once. The aqueous fraction (about 800 µL) was transferred into a new Eppendorf tube and 800 µL of 2-isopropanol was added to precipitate RNA at room temperate for 20 min. After centrifugation at 12,000 rpm at 4°C for 15 min and removal of the supernatant, 1 mL of 75% ethanol was added to wash the RNA precipitate, followed by centrifugation at 12,000 rpm at 4°C for 10 min. After the ethanol was discarded, the RNA precipitate was dissolved in 20 µL of water pre-treated with diethylpyrocarbonate (DEPC) (Sigma-Aldrich Company, USA). The RNA samples extracted from the same SF specimen were pooled and concentrated by precipitation with ethanol, and then suspended in DEPC water and stored at -80°C.
Establishment of cDNA library
Since this study was to test whether the liquid fraction of SF contained enough RNA for sequencing, one sample with the smallest amount of RNA was selected and designated as “sample Li”, and another sample with a relatively larger amount of RNA, designated as “sample Niu”. Both patients did not manifest any obvious systemic infection or infection of the affected knee joint, according to the results of various clinical or laboratory examinations. As shown in Table 1, both the quantity and the quality of the RNA samples were poor, far worse than what was routinely used for RNA sequencing.
Table 1.
Quality of RNA samples from liquid fraction of synovial fluid
Sample | Concen. (µg/µL) | Vol. (µL) | Total RNA (µg) | OD260/280 | OD260/230 | 28S-18S | RIN |
---|---|---|---|---|---|---|---|
Li | 4 | 24 | 0.096 | 0.8 | 0.106 | 0 | 0 |
Niu | 10 | 24 | 0.24 | 1.172 | 0.23 | 0 | 1.2 |
Note: “0”, “Concen.”, “Vol.”, and “RIN” mean undetectable, concentration, total volume, and RNA integrity number, respectively.
The RNA samples were mixed with a fragmentation buffer (AM8740, Ambion, Inc., An Applied Biosystems Business; www.ambion.com) to fragment RNAs, followed by reverse transcription to the first strand cDNA with random hexamers as routine. The second strand of the cDNAs was synthesized in the presence of RNase H, using DNA polymerase I (Sigma-aldrich Company, USA) with the addition of dATP, dCTP, dGTP and dUTP (Promega Corporation, USA), followed by purification of double-stranded cDNAs using Agencourt AMPure XP beads (www.beckmancoulter.com). The purified cDNA fragments were appended with dATP, dCTP, dGTP and dUTP, using Taq DNA polymerase (Promega Corporation, USA), followed by ligation to adapters and then fragment selection using Agencourt AMPure XP beads again. After degradation of the dU-containing single-stranded cDNAs using an USER enzyme (M5505, NEB, www.neb.com), the DNA fragments were amplified with 8 cycles of polymerase chain reaction (PCR). The PCR products were purified again using Agencourt AMPure XP beads (BeckmanCoulter Company, USA) to establish the cDNA library. The key steps of the library establishment are depicted in Figure 1.
Figure 1.
Procedure of establishment of cDNA library.
cDNA sequencing, sequence alignment, and gene clustering
The cDNA library was quantified with Qubit 2.0 (Invitrogen, USA) and diluted to 1.5 ng/µL, followed by determination of the insert sizes using Agilent 2100 (Agilent Technologies, USA). Quantitative-PCR was used to further quantify it to ensure proper cDNA quality and quantity for sequencing. The cDNA library was subjected to the second-generation sequencing using HisSeq4000 at Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China, with a data size of 8G.
The sequencing reads were aligned to the UCSC human reference genome (hg38) using Tophat v.2.0.9 software program with default parameters (Johns Hopkins University, Baltimore, MD, USA). Tophat uses the Bowtie2 algorithm to perform the alignment by removing the parts of the reads that fail to pass the quality control while mapping the qualified reads to the reference genome. Normalized read counts were calculated to fragments per kilobase of transcript per million mapped reads (FPKM). Gene function enrichment was generated by DAVID (https://david.ncifcrf.gov/), which is a web-based tool designed for gene annotation and functional clustering.
Statistical analysis
The measured data were represented by mean ± standard deviation. The enumerated data were expressed as percentage or rate. SPSS 23.0 software (Shanghai Yuchuang Network Technology, China) was used for all statistical analyses. Differences between the sample Niu and Li were analyzed by Student’s t-test or chi square test. P<0.05 indicated statistical significance.
Results
Sequencing data
As shown in Table 1, cDNA library from 0.096 µg (sample Li) and 0.24 µg (sample Niu) RNA were established. In the simple Li, the second-generation sequencing produced 66,154,562 clean reads, 91.28% of which were matched to the human genome with a total of 2,682 genes identified, as shown in Table 2. Since these identified “genes” included different types of non-coding RNAs, including microRNAs and antisense RNAs, as seen in Figure 2A, all detected genes were referred to as “RNA genes”, which covered both protein-coding and noncoding RNAs, to distinguish them from classically annotated genes.
Table 2.
Matched reads and genes identified from sequencing
Sample | Clean reads* | Reads matched | Mapped ratio | Genes |
---|---|---|---|---|
Li | 66,154,562 (33,077,281 pairs) | 60,383,101 | 91.28% | 2,682 |
Niu | 64,463,162 (32,231,581 pairs) | 14,441,399 | 22.40% | 5,081 |
Those reads that had five nucleotides unmatchable to the reference were excluded.
Figure 2.
Distribution of detected RNA genes into different gene categories in samples. A: Different RNA gene categories in Sample Li; B: Distribution of RNA genes in Sample Niu. Note: LincRNA: long intervening noncoding RNA; misc_RNA: miscellaneous RNA; TEC: to be experimentally confirmed; IG_V_pseudogene: immunoglobulin_V_pseudogene; IG_V_gene: immunoglobulin_V_gene; Mt_rRNA: mitochondrial rRNA; TR_V_pseudogene: T cell receptor_V_pseudogene; snoRNA: small nuclear RNA; IG_C_gene: immunoglobulin_C_gene.
The sample Niu was much better in quality and quantity, as shown in Table 1, and 64,463,162 clean reads were obtained from the sample Niu. Interestingly, only 22.40%, i.e. 14,441,399 of the reads were matched to the human genome, although 5,081 genes were identified, many more than the 2,682 genes identified in sample Li, as shown in Table 2. Since the match rate was surprisingly low, whether the RNA sample contained alien RNAs from microorganisms was analyzed (Figure 2B). We thus aligned the unmatched 50,021,763 reads to the nucleotide collections of the NCBI (National Center for Biotechnology Information, USA), and obtained 40,082 matched reads, 25,205 of which had a coverage of over 60%. Interestingly, 20,109 (79.78%) of these 25,205 reads were matched to pseudomonas, a genus of Gram-negative, aerobic Gamma-proteobacteria. This result confirmed that the SF sample contained alien RNAs, which was one of the reasons for the low match rate to the human RNA transcripts.
Bioinformatic analyses of identified genes
According to the number of the genes in each category, distribution of all identified RNA genes to different categories revealed that most detected genes were protein-coding ones, processed pseudogenes, long noncoding RNAs (lincRNAs), antisense RNAs, miscellaneous RNAs, and unprocessed pseudogenes. However, many other types of RNAs were also detected at a lower abundance in both Li and Niu samples, as shown in Figure 2.
Arrangement of the identified RNA genes in the order of their expression abundance showed that the ten most abundantly expressed genes were protein coding ones. These were was similar between the two samples. Interestingly, 80% of genes were encoded by the mitochondrial genome, which was highly similar between the two samples as well, as shown in Table 3. This indicated that these mitochondrial RNAs were either highly expressed or more stable in the viscous SF.
Table 3.
Ten most abundantly expressed genes
Li | Niu |
---|---|
NEDD4 | MT-ND6 |
BLOC1S6 | NEDD4 |
MT-ND6 | MT-ND5 |
MT-ND4 | MT-ND4 |
MT-ND5 | BLOC1S6 |
MT-CYB | MT-CYB |
MT-ND2 | MT-ND2 |
MT-ATP8 | MT-ND4L |
MT-CO2 | MT-CO2 |
MT-ATP6 | MT-CO1 |
As shown in Figure 3, the bioinformatic analyses also showed that the two samples were similar in the subcellular localizations of the detected RNA genes, which included different organelles, macromolecular complexes, and even extracellular regions. As expected, cellular components, metabolic processes, and multicellular processes were among the main biologic functions with the most RNA genes detected. Consistent with these results, most detected RNA genes were found to be related to sort of binding activity or catalytic activity among various molecular functions.
Figure 3.
Distribution of detected RNA genes for different subcellular or functional categories, arranging in the percentage occupied by this number in the total identified genes from samples. A: Sample Li; B: Sample Niu.
The analysis of molecular pathways revealed that cancer-related pathways were the most prominent in both samples. However, the two samples were distinguished from each other by many other pathways. As shown in Table 4, for example, the PI3K-Akt and the focal adhesion signaling pathways were identified in sample Niu but not in sample Li. Fewer molecular signaling pathways were identified in sample Li, in part because fewer genes were identified than in sample Niu.
Table 4.
KEGG analyses of gene distribution to various functional signaling pathways according to their read counts
Sample | Li | Niu | |||||
---|---|---|---|---|---|---|---|
|
|
||||||
Term | Count | % | P value | Term | Count | % | P value |
hsa05200: Pathways in cancer | 44 | 3.049203 | 0.023812 | hsa05200: Pathways in cancer | 70 | 2.659574 | 0.04867 |
hsa03013: RNA transport | 34 | 2.356202 | 1.96E-06 | hsa04151: PI3K-Akt signaling pathway | 66 | 2.507599 | 0.014145 |
hsa05169: Epstein-Barr virus infection | 27 | 1.871102 | 0.005192 | hsa04510: Focal adhesion | 46 | 1.74772 | 0.002661 |
hsa05202: Transcriptional misregulation in cancer | 23 | 1.593902 | 0.015794 | hsa04810: Regulation of action cytoskeleton | 42 | 1.595745 | 0.028737 |
hsa03040: Spliceosome | 21 | 1.455301 | 0.004734 | hsa05205: Proteoglycans in cancer | 41 | 1.557751 | 0.019779 |
hsa04068: FoxO signaling pathway | 19 | 1.316701 | 0.02169 | hsa05203: Viral Carcinogenesis | 41 | 1.557751 | 0.028682 |
hsa04611: Platelet activation | 18 | 1.247401 | 0.03177 | hsa03013: RNA transport | 35 | 1.329787 | 0.034929 |
hsa04110: Cell cycle | 17 | 1.178101 | 0.040597 | hsa03040: Spliceosome | 31 | 1.177812 | 0.008055 |
hsa03015: mRNA surveillance pathway | 16 | 1.108801 | 0.00582 | hsa04068: FoxO signaling pathway | 30 | 1.139818 | 0.016021 |
hsa04919: Thyroid hormone signaling pathway | 16 | 1.108801 | 0.04007 | hsa03010: Ribosome | 29 | 1.101824 | 0.031774 |
hsa00650: Butanoate metabolism | 7 | 0.4851 | 0.018468 | hsa04919: Thyroid hormone signaling pathway | 26 | 0.987842 | 0.020687 |
hsa03060: Protein export | 6 | 0.4158 | 0.033538 | hsa04512: ECM-receptor interaction | 23 | 0.87386 | 0.005493 |
hsa05100: Bacterial invasion of epithelial cells | 22 | 0.835866 | 0.00298 | ||||
hsa04666: Fc gamma R-mediated phagocytosis | 20 | 0.759878 | 0.030033 | ||||
hsa05222: Small cell lung cancer | 20 | 0.759878 | 0.033609 | ||||
hsa05213: Endometrial cancer | 14 | 0.53915 | 0.031693 | ||||
hsa04621: NOD-like receptor signaling pathway | 14 | 0.53915 | 0.048042 | ||||
hsa00650: Butanoate metabolism | 10 | 0.379939 | 0.01114 |
Discussion
Although synovial fluid (SF) is very viscous, a routine procedure including removal of cells by a low speed centrifugation and removal of proteins with Trizol and chloroform, was able to supply a sufficient amount, that is less than 0.1 µg, of RNA, for establishment of a cDNA library and the ensuing second generation DNA sequencing. This tiny amount of RNA is the smallest known quantity sufficient for this purpose, but whether an even lesser quantity of RNA is also sufficient for this purpose is unknown. A pretreatment of the SF with a hyaluronidase may decrease the viscosity and increase the yield of RNA, especially small RNAs that may be hard to precipitate from the viscous SF [12,13]. However, this additional step may also degrade some long RNAs. Peers may consider this step by balancing its strength against its weakness.
One ethical constraint for study of the transcriptome in SF is the difficulty in collecting SF from healthy individuals with comparable gender and age [14]. There were also reasons that we were not able to include normal SF samples for comparison. As introduced earlier, most relevant studies analyzed the transcriptome by comparing different subtypes of arthritis, such as comparison of OA with rheumatoid arthritis, using cells from SF or directly using different joint tissues or synovial tissues [15,16]. While these studies on tissues or cells may provide us with clues for how a particular synovial tissue or cell type may be involved in joint diseases, they do not provide us with a general picture of the gene expression profile in SF in general and in the liquid fraction of SF in particular [17,18]. This study showed that the liquid fraction of SF contains a whole RNA repertoire, of which those derived from the mitochondrial genome were the most abundant in terms of expression level. These RNAs must either be secreted from synovial cells or tissues or be derived from dregs of various cell types in SF, which in turn either be shed off from synovial tissues or be cells in SF per se. Since SF cells may have died a long time ago, the data seem to suggest that SF can maintain RNAs at a relatively high quality for a long time.
Prominent cancer-related pathways were identified to be the most prominent ones in both samples [19], which is somewhat unexpected. Since cancer-related pathways are characterized mainly by promotion of cell proliferation and/or inhibition of cell differentiation and cell death, it seems SF cells or synovial tissues have a high cell turnover, i.e. quick cell proliferation and differentiation in association with quick cell death [20,21]. This is reasonable because knee joints have much activity every day, which may cause death of many cells.
The two samples studied had disparities in the RNA repertoire. The disparities mainly occurs in the terms for the molecular pathways. Compared with sample Li, sample Niu displayed more-diversified and more-complex signaling pathways. Interestingly, some pathways or cellular processes related to viral infection showed activity in both samples. It is possible that OA may be related to abnormal immune activity or that knee joints are actually easily infected by viruses, although some of the infections may not be virulent and cause disease [22-24]. These possibilities await verification with more samples and with a proper control of SF from healthy individuals.
An unexpected finding in our study is that a large portion of clean reads were unmatchable to the human genome, especially in sample Niu that had 77.60% of the clean reads being unmatchable. Even in sample Li there still were 8.72% of the reads being unmatchable, which is higher than most of other RNA samples from cells or tissues in our long-term practice in RNA deep sequencing. Some of these unmatchable reads may be technical spuriousness derived from RT or PCR, as one of us has described previously [25-29]. Another possibility may be a contribution from alien RNAs, i.e. those from microorganisms such as virus, bacteria, or fungi [30-32]. This is indeed one of the reasons for sample Niu from which we found that many of the clean but unmatchable reads were matched to bacteria, mainly Pseudomonas, some strains of which are known human pathogens [33,34]. Considering that the two patients did not have any obvious systemic infection or infection of the affected knee joint at the time of sample collection, as shown by all clinical and laboratory examinations, these foreign RNAs should be remains of microorganisms from previous infections, some of which may not even be virulent enough to cause noticeable infection, especially considering that the analyses of molecular pathways suggest a higher immune activity in the SF. The observation that these alien RNAs became long-lasting in SF may indicate that SF has little nuclease activity and its viscous nature helps to stabilize RNAs. If so, the transcriptome of the liquid fraction of SF may provide us with clues for not only the current, but also previous infection(s) by microorganisms, including those that are less virulent. This point, and whether these foreign RNAs have any beneficial or detrimental effects on the joint, deserve further investigations [35,36].
In conclusion, this study showed that an amount of RNA less than 0.1 µg could be used to establish a cDNA library for sequencing. The cell-free liquid fraction of SF contains a whole RNA repertoire consisting of most RNA categories, including protein-coding ones and different non-coding regulatory ones, with the most abundantly expressed ones being derived from the mitochondrial genome. These RNAs participate in most biological functions and cellular processes, including cancer-related pathways and transcriptional regulations. Interestingly, the liquid component of SF also contains a significant amount of alien RNAs that likely belong microorganisms that previously infected the joint, which suggests that SF may have little nuclease activity and is capable of sustaining the integrity of RNAs for a long time.
This study has some limitations that should be noted. First, the sample size was inadequate. Second, this research was performed in a single center. Third, the mechanisms of signal transduction system for RNAs expression were not further detected. Therefore, conducting a multicenter, randomized controlled and large-sample clinical study to confirm the roles of RNAs in biologic functions and cellular processes during development of KOA is warranted to more precisely guidelines in prevention and treatment of KOA.
Acknowledgements
We would like to thank Dr. Fred Bogott at Austin Medical Center, Austin of Minnesota, for his excellent English editing of the manuscript.
Disclosure of conflict of interest
None.
References
- 1.Ondresik M, Azevedo Maia FR, da Silva Morais A, Gertrudes AC, Dias Bacelar AH, Correia C, Goncalves C, Radhouani H, Amandi Sousa R, Oliveira JM, Reis RL. Management of knee osteoarthritis. Current status and future trends. Biotechnol Bioeng. 2017;114:717–739. doi: 10.1002/bit.26182. [DOI] [PubMed] [Google Scholar]
- 2.GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1659–1724. doi: 10.1016/S0140-6736(16)31679-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, Goldring MB, Goldring SR, Jones G, Teichtahl AJ, Pelletier JP. Osteoarthritis. Nat Rev Dis Primers. 2016;2:16072. doi: 10.1038/nrdp.2016.72. [DOI] [PubMed] [Google Scholar]
- 4.Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Curr Opin Rheumatol. 2018;30:160–167. doi: 10.1097/BOR.0000000000000479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Jones G. What’s new in osteoarthritis pathogenesis? Intern Med J. 2016;46:229–236. doi: 10.1111/imj.12763. [DOI] [PubMed] [Google Scholar]
- 6.Lauwerys BR, Hernandez-Lobato D, Gramme P, Ducreux J, Dessy A, Focant I, Ambroise J, Bearzatto B, Nzeusseu Toukap A, Van den Eynde BJ, Elewaut D, Gala JL, Durez P, Houssiau FA, Helleputte T, Dupont P. Heterogeneity of synovial molecular patterns in patients with arthritis. PLoS One. 2015;10:e0122104. doi: 10.1371/journal.pone.0122104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.van der Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, Huizinga TW. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum. 2007;56:433–440. doi: 10.1002/art.22380. [DOI] [PubMed] [Google Scholar]
- 8.Oliviero F, Galozzi P, Ramonda R, de Oliveira FL, Schiavon F, Scanu A, Punzi L. Unusual findings in synovial fluid analysis: a review. Ann Clin Lab Sci. 2017;47:253–259. [PubMed] [Google Scholar]
- 9.Altobelli E, Angeletti PM, Piccolo D, De Angelis R. Synovial fluid and serum concentrations of inflammatory markers in rheumatoid arthritis, psoriatic arthritis and osteoarthitis: a systematic review. Curr Rheumatol Rev. 2017;13:170–179. doi: 10.2174/1573397113666170427125918. [DOI] [PubMed] [Google Scholar]
- 10.Bhattaram P, Chandrasekharan U. The joint synovium: a critical determinant of articular cartilage fate in inflammatory joint diseases. Semin Cell Dev Biol. 2017;62:86–93. doi: 10.1016/j.semcdb.2016.05.009. [DOI] [PubMed] [Google Scholar]
- 11.Legrand CB, Lambert CJ, Comblain FV, Sanchez C, Henrotin YE. Review of soluble biomarkers of osteoarthritis: lessons from animal models. Cartilage. 2017;8:211–233. doi: 10.1177/1947603516656739. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Steinberg J, Zeggini E. Functional genomics in osteoarthritis: past, present, and future. J Orthop Res. 2016;34:1105–1110. doi: 10.1002/jor.23296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mickiewicz B, Heard BJ, Chau JK, Chung M, Hart DA, Shrive NG, Frank CB, Vogel HJ. Metabolic profiling of synovial fluid in a unilateral ovine model of anterior cruciate ligament reconstruction of the knee suggests biomarkers for early osteoarthritis. J Orthop Res. 2015;33:71–77. doi: 10.1002/jor.22743. [DOI] [PubMed] [Google Scholar]
- 14.Del Rey MJ, Usategui A, Izquierdo E, Cañete JD, Blanco FJ, Criado G, Pablos JL. Transcriptome analysis reveals specific changes in osteoarthritis synovial fibroblasts. Ann Rheum Dis. 2012;71:275–280. doi: 10.1136/annrheumdis-2011-200281. [DOI] [PubMed] [Google Scholar]
- 15.Xu JF, Zhang SJ, Zhao C, Qiu BS, Gu HF, Hong JF, Cao L, Chen Y, Xia B, Bi Q, Wang YP. Altered microRNA expression profile in synovial fluid from patients with knee osteoarthritis with treatment of hyaluronic acid. Mol Diagn Ther. 2015;19:299–308. doi: 10.1007/s40291-015-0155-2. [DOI] [PubMed] [Google Scholar]
- 16.Pandis I, Ospelt C, Karagianni N, Denis MC, Reczko M, Camps C, Hatzigeorgiou AG, Ragoussis J, Gay S, Kollias G. Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model. Ann Rheum Dis. 2012;71:1716–1723. doi: 10.1136/annrheumdis-2011-200803. [DOI] [PubMed] [Google Scholar]
- 17.Li J, Wan Y, Guo Q, Zou L, Zhang J, Fang Y, Zhang J, Zhang J, Fu X, Liu H, Lu L, Wu Y. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther. 2010;12:R81. doi: 10.1186/ar3006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Heard BJ, Martin L, Rattner JB, Frank CB, Hart DA, Krawetz R. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid. BMC Musculoskelet Disord. 2012;13:126. doi: 10.1186/1471-2474-13-126. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ritter SY, Subbaiah R, Bebek G, Crish J, Scanzello CR, Krastins B, Sarracino D, Lopez MF, Crow MK, Aigner T, Goldring MB, Goldring SR, Lee DM, Gobezie R, Aliprantis AO. Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues. Arthritis Rheum. 2013;65:981–992. doi: 10.1002/art.37823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Yang P, Tan J, Yuan Z, Meng G, Bi L, Liu J. Expression profile of cytokines and chemokines in osteoarthritis patients: proinflammatory roles for CXCL8 and CXCL11 to chondrocytes. Int Immunopharmacol. 2016;40:16–23. doi: 10.1016/j.intimp.2016.08.005. [DOI] [PubMed] [Google Scholar]
- 21.Rump L, Mattey DL, Kehoe O, Middleton J. An initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium. Cytokine. 2017;97:133–140. doi: 10.1016/j.cyto.2017.05.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Lorenz P, Ruschpler P, Koczan D, Stiehl P, Thiesen HJ. From transcriptome to proteome: differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies. Proteomics. 2003;3:991–1002. doi: 10.1002/pmic.200300412. [DOI] [PubMed] [Google Scholar]
- 23.Wang X, Ning Y, Guo X. Integrative meta-analysis of differentially expressed genes in osteoarthritis using microarray technology. Mol Med Rep. 2015;12:3439–3445. doi: 10.3892/mmr.2015.3790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Liu T, Lin X, Yu H. Identifying genes related with rheumatoid arthritis via system biology analysis. Gene. 2015;571:97–106. doi: 10.1016/j.gene.2015.06.058. [DOI] [PubMed] [Google Scholar]
- 25.Peng Z, Yuan C, Zellmer L, Liu S, Xu N, Liao DJ. Hypothesis: artifacts, including spurious chimeric RNAs with a short homologous sequence, caused by consecutive reverse transcriptions and endogenous random primers. J Cancer. 2015;6:555–567. doi: 10.7150/jca.11997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Xie B, Yang W, Ouyang Y, Chen L, Jiang H, Liao Y, Liao DJ. Two RNAs or DNAs may artificially fuse together at a short homologous sequence (SHS) during reverse transcription or polymerase chain reactions, and thus reporting an SHS-containing chimeric RNA requires extra caution. PLoS One. 2016;11:e0154855. doi: 10.1371/journal.pone.0154855. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Yang W, Wu JM, Bi AD, Ou-Yang YC, Shen HH, Chirn GW, Zhou JH, Weiss E, Holman EP, Liao DJ. Possible formation of mitochondrial-RNA containing chimeric or trimeric RNA implies a post-transcriptional and post-splicing mechanism for RNA fusion. PLoS One. 2013;8:e77016. doi: 10.1371/journal.pone.0077016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Yuan C, Liu Y, Yang M, Liao DJ. New methods as alternative or corrective measures for the pitfalls and artifacts of reverse transcription and polymerase chain reactions (RT-PCR) in cloning chimeric or antisense-accompanied RNA. RNA Biol. 2013;10:958–967. doi: 10.4161/rna.24570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Yuan C, Han Y, Zellmer L, Yang W, Guan Z, Yu W, Huang H, Liao DJ. It is imperative to establish a pellucid definition of chimeric RNA and to clear up a lot of confusion in the relevant research. Int J Mol Sci. 2017;18:714. doi: 10.3390/ijms18040714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Xu Y, Huang Y, Cai D, Liu J, Cao X. Analysis of differences in the molecular mechanism of rheumatoid arthritis and osteoarthritis based on integration of gene expression profiles. Immunol Lett. 2015;168:246–253. doi: 10.1016/j.imlet.2015.09.011. [DOI] [PubMed] [Google Scholar]
- 31.Dennis G Jr, Holweg CT, Kummerfeld SK, Choy DF, Setiadi AF, Hackney JA, Haverty PM, Gilbert H, Lin WY, Diehl L, Fischer S, Song A, Musselman D, Klearman M, Gabay C, Kavanaugh A, Endres J, Fox DA, Martin F, Townsend MJ. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res Ther. 2014;16:R90. doi: 10.1186/ar4555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lewallen EA, Bonin CA, Li X, Smith J, Karperien M, Larson AN, Lewallen DG, Cool SM, Westendorf JJ, Krych AJ, Leontovich AA, Im HJ, van Wijnen AJ. The synovial microenvironment of osteoarthritic joints alters RNA-seq expression profiles of human primary articular chondrocytes. Gene. 2016;591:456–464. doi: 10.1016/j.gene.2016.06.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Bijnsdorp IV, van Royen ME, Verhaegh GW, Martens-Uzunova ES. The non-coding transcriptome of prostate cancer: implications for clinical practice. Mol Diagn Ther. 2017;21:385–400. doi: 10.1007/s40291-017-0271-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.McCallie BR, Parks JC, Griffin DK, Schoolcraft WB, Katz-Jaffe MG. Infertility diagnosis has a significant impact on the transcriptome of developing blastocysts. Mol Hum Reprod. 2017;23:549–556. doi: 10.1093/molehr/gax034. [DOI] [PubMed] [Google Scholar]
- 35.Kremer LS, Bader DM, Mertes C, Kopajtich R, Pichler G, Iuso A, Haack TB, Graf E, Schwarzmayr T, Terrile C, Konarikova E, Repp B, Kastenmuller G, Adamski J, Lichtner P, Leonhardt C, Funalot B, Donati A, Tiranti V, Lombes A, Jardel C, Glaser D, Taylor RW, Ghezzi D, Mayr JA, Rotig A, Freisinger P, Distelmaier F, Strom TM, Meitinger T, Gagneur J, Prokisch H. Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat Commun. 2017;8:15824. doi: 10.1038/ncomms15824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Gao M, Zhong A, Patel N, Alur C, Vyas D. High throughput RNA sequencing utility for diagnosis and prognosis in colon diseases. World J Gastroenterol. 2017;23:2819–2825. doi: 10.3748/wjg.v23.i16.2819. [DOI] [PMC free article] [PubMed] [Google Scholar]